Format
Sort by

Send to

Choose Destination

Search results

Items: 11

1.

Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma.

Rule WG, Allred JB, Pockaj BA, Markovic SN, DiCaudo DJ, Erickson LA, Deming RL, Schild SE.

Cancer Med. 2016 Aug;5(8):1890-6. doi: 10.1002/cam4.783.

2.

RE: Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.

Schild SE, Ashman JB, Keole SR, Daniels TB, Rule WG.

J Natl Cancer Inst. 2016 Jan 7;108(3). pii: djv412. doi: 10.1093/jnci/djv412. No abstract available.

PMID:
26744478
3.

Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer.

Anand A, Bues M, Rule WG, Keole SR, Beltran CJ, Yin J, Haddock MG, Hallemeier CL, Miller RC, Ashman JB.

Radiother Oncol. 2015 Dec;117(3):505-8. doi: 10.1016/j.radonc.2015.10.027.

PMID:
26597231
4.

A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases.

Meyer JJ, Foster RD, Lev-Cohain N, Yokoo T, Dong Y, Schwarz RE, Rule W, Tian J, Xie Y, Hannan R, Nedzi L, Solberg T, Timmerman R.

Ann Surg Oncol. 2016 Jan;23(1):218-24. doi: 10.1245/s10434-015-4579-z.

5.

Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis.

Rule WG, Foster NR, Meyers JP, Ashman JB, Vora SA, Kozelsky TF, Garces YI, Urbanic JJ, Salama JK, Schild SE.

J Geriatr Oncol. 2015 Mar;6(2):119-26. doi: 10.1016/j.jgo.2014.11.002.

PMID:
25482023
6.

Proton beam therapy for locally advanced lung cancer: A review.

Schild SE, Rule WG, Ashman JB, Vora SA, Keole S, Anand A, Liu W, Bues M.

World J Clin Oncol. 2014 Oct 10;5(4):568-75. doi: 10.5306/wjco.v5.i4.568. Review.

7.

Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer.

Ashman JB, Moss AA, Rule WG, Callister MG, Reddy KS, Mulligan DC, Collins JM, De Petris G, Gunderson LL, Borad M.

J Gastrointest Oncol. 2013 Dec;4(4):352-60. doi: 10.3978/j.issn.2078-6891.2013.006.

8.

Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.

Warner S, Chang YH, Paripati H, Ross H, Ashman J, Harold K, Day R, Stucky CC, Rule W, Jaroszewski D.

Ann Thorac Surg. 2014 Feb;97(2):439-45. doi: 10.1016/j.athoracsur.2013.09.042.

PMID:
24266955
9.

Current status of radiation therapy for the management of rectal cancer.

Rule W, Meyer J.

Crit Rev Oncog. 2012;17(4):331-43. Review.

PMID:
23176041
10.

Rib fracture following stereotactic body radiotherapy: a potential pitfall.

Stanic S, Boike TP, Rule WG, Timmerman RD.

Clin Nucl Med. 2011 Nov;36(11):e168-70. doi: 10.1097/RLU.0b013e318219b539.

PMID:
21975415
11.

Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases.

Rule W, Timmerman R, Tong L, Abdulrahman R, Meyer J, Boike T, Schwarz RE, Weatherall P, Chinsoo Cho L.

Ann Surg Oncol. 2011 Apr;18(4):1081-7. doi: 10.1245/s10434-010-1405-5.

PMID:
21046264
Items per page

Supplemental Content

Loading ...
Support Center